Brief: Kancera Applies For New Patent For Drug Candidates KAND567 And KAND145
May 8 (Reuters) - Kancera AB KANC.ST :
* APPLIES FOR NEW PATENT FOR DRUG CANDIDATES KAND567 AND
KAND145
Source text for Eikon: ID:nWkr5QgHYS
Further company coverage: KANC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing